Latest revenue
$83.3K
as of 2026-03-31
Latest net income
$-678.1K
as of 2026-03-31
Net margin
-813.7%
as of 2026-03-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Services-Prepackaged Software (227 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.
Community sentiment
Where do you think AMST is heading?
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $7.8M
- Enterprise value
- $9.2M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- 5.98×
- Dividend yield
- 0.0%
- 52-wk high
- $4.78
- 52-wk low
- $0.77
- Beta
- —
- Shares out
- 5.9M
5-year trend
What this company does
ITEM 1. BUSINESS Overview Amesite is a technology company focused on building and commercializing AI-powered solutions for the healthcare sector, with particular emphasis on the post-acute care market. In fiscal 2025, we completed our pivot from an education-centric model to one firmly anchored in the demands and opportunities of healthcare—a shift driven by the scale, complexity, and attractive growth potential of this sector. We operate through two product lines under our NurseMagic™ brand: a B2C (direct-to-practitioner) app and a B2B (enterprise) platform. These solutions directly address operational, compliance, and efficiency challenges faced by healthcare professionals and…
AI summary unavailable — showing raw filing excerpt
Generated from AMST's filing dated 2025-09-29
Key risks
ITEM 1A. RISK FACTORS You should carefully consider the risks described below, as well as general economic and industry risks and other information in this Annual Report on Form 10-K. Adverse events in any of these areas could materially and negatively impact our business, financial condition, and results of operations. Additional risks or uncertainties not presently known or deemed immaterial may also harm our business. Risks Related to Our Healthcare and AI Solutions Business Compliance and Regulatory Risks Our NurseMagic™ solution is designed for use across post-acute healthcare settings, including skilled nursing, assisted living, memory care, home health, and rehabilitation. The…
AI summary unavailable — showing raw filing excerpt
Generated from AMST's filing dated 2025-09-29
Profitability
Operating margin
-3262.4%
18.9%Net margin
-3274.6%
24.1%Return on equity
-132.1%
24.5%Return on assets
-116.8%
12.1%Leverage
Debt / equity
0.13×
58.7%Debt / assets
11.6%
51.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $83.3K | +171.5% | $-678.1K | -2.2% | -813.7% |
Q4 2025 2025-12-31 | $108.0K | +746.8% | $-732.5K | +34.7% | -678.0% |
Q3 2025 2025-09-30 | $94.3K | +738.2% | $-642.3K | +29.3% | -681.1% |
Q2 2025 2025-06-30 | $55.8K | +100.3% | $-924.0K | +21.8% | -1657.1% |
Q1 2025 2025-03-31 | $30.7K | -10.4% | $-663.4K | +53.5% | -2161.7% |
Q4 2024 2024-12-31 | $12.8K | -69.2% | $-1.1M | -23.9% | -8790.3% |
Q3 2024 2024-09-30 | $11.3K | -82.2% | $-908.0K | -1.9% | -8071.5% |
Q2 2024 2024-06-30 | $27.8K | — | $-1.2M | — | -4241.4% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Prepackaged Software · SIC 7372
Your notes
Keep private notes on AMST — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$600.0K
Insider selling
$0
Net activity
+$600.0K
Distinct insiders
2
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns AMST
Institutional value
$96.5K
Total shares held
52.5K
Distinct holders
6
-7 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 30.2K | $55.6K | — | New |
| 2 | VANGUARD FIDUCIARY TRUST CO | 13.8K | $25.3K | — | New |
| 3 | JPMORGAN CHASE & CO | 5.9K | $10.6K | +0 (+0.0%) | No change |
| 4 | UBS Group AG | 2.7K | $4.9K | — | New |
| 5 | Caitong International Asset Management Co., Ltd | 3 | $6 | — | New |
| 6 | CITIGROUP INC | 1 | $2 | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once AMST's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.